Abbott Laboratories's Corporate Customers have recorded an advance in their cost of revenue by 8.3 % in the 1 quarter 2026 year on year, sequentially costs of revenue were trimmed by -6.06 %. During the corresponding time, Abbott Laboratories recorded a revenue increase by 7.78 % year on year, sequentially revenue fell by -2.57 %. While revenue at the Abbott Laboratories's corporate clients recorded rose by 5.51 % year on year, sequentially revenue fell by -2.34 %.
Abbott Laboratories's Customers have recorded an advance in their cost of revenue by 8.3 % in the 1 quarter 2026 year on year, sequentially costs of revenue were trimmed by -6.06 %, for the same period Abbott Laboratories recorded revenue increase by 7.78 % year on year, sequentially revenue fell by -2.57 %.
Abbott Laboratories's Comment on Sales, Marketing and Customers
Abbott's Diagnostic Products segment provides products and services to customers worldwide, including blood banks, hospitals, commercial laboratories, clinics, physicians’ offices, retailers, government agencies, alternate care testing sites, and plasma protein therapeutic companies. The segment offers core laboratory and transfusion medicine systems, molecular diagnostics PCR instrument systems, point-of-care systems, rapid diagnostics lateral flow testing products, cardiometabolic testing platforms, toxicology testing, and informatics and automation solutions for various care settings.
Abbott Laboratories’s Comment on Sales, Marketing and Customers
Abbott's Diagnostic Products segment provides products and services to customers worldwide, including blood banks, hospitals, commercial laboratories, clinics, physicians’ offices, retailers, government agencies, alternate care testing sites, and plasma protein therapeutic companies. The segment offers core laboratory and transfusion medicine systems, molecular diagnostics PCR instrument systems, point-of-care systems, rapid diagnostics lateral flow testing products, cardiometabolic testing platforms, toxicology testing, and informatics and automation solutions for various care settings.
Sources:
Abbott Laboratories’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Abbott Laboratories’s corporate clients.
For your research, we’ve provided 9 tables on Abbott Laboratories corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
38.28 %
5.52 % 